Garuda - Garba Rujukan Digital

p-Index From 2021 - 2026

4.269

P-Index

This Author published in this journals

All Journal Jurnal Ilmiah Farmasi The Journal of Experimental Life Sciences (JELS) Biotropika Pelita Perkebunan Folia Medica Indonesiana Jurnal Farmasi Klinik Indonesia Majalah Kulit, Karet, dan Plastik Jurnal Ilmu Farmasi dan Farmasi Klinik (Journal of Pharmaceutical Science and Clinical Pharmacy) Pharmacon Journal of Tropical Biodiversity and Biotechnology INDONESIAN JOURNAL OF PHARMACY Pharmascience Journal of Islamic Pharmacy JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Jurnal Farmasi Sains dan Komunitas Journal of Islamic Medicine JSFK (Jurnal Sains Farmasi & Klinis) PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Manuju : Malahayati Nursing Journal JFIOnline J-Dinamika: Jurnal Pengabdian Kepada Masyarakat Jurnal Farmasi Higea Pharmacoscript An-Nadaa: Jurnal Kesehatan Masyarakat Pharma Xplore : Jurnal Sains dan Ilmu Farmasi ad-Dawaa : Journal of Pharmaceutical Sciences Jurnal Layanan Masyarakat (Journal of Public Service) Journal of Community Development Berkala Penelitian Hayati Pharmaceutical Sciences and Research (PSR) Agrimas : Jurnal Pengabdian Masyarakat Bidang Pertanian Jurnal Farmasi Sains dan Terapan (Journal of Pharmacy Science and Practice)

Suharjono, Suharjono

Faculty Of Pharmacy, Universitas Airlangga

Author-ID : 389234

Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemistry Computer Science & IT Decision Sciences, Operations Research & Management Education Engineering Environmental Science Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences Veterinary Other

Published : 66 Documents Claim Missing Document

Claim Missing Document

Articles

1 2 3 4 5

Potential Drug–Drug Interactions in Ambulatory Patients with Hypertension: a Retrospective Study Marcha Debby Saraswati; Shafira Muti Ardiana; Budi Suprapti; M. Yusuf Assegaf; Suharjono Suharjono; Khusnul Fitri Hamidah
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 9 No. 1 (2022): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v9i12022.69-74

Background: Patients with cardiovascular diseases (CVD) are vulnerable to experiencing drug-drug interactions (DDIs). DDIs are a concern among patients receiving multiple drug regimens but they are also an avoidable cause of adverse drug reactions. The study of potential DDIs (pDDIs) would make it easier for the healthcare provider to deliver better patient care and mitigate pDDIs incidence. Objective: This study aimed to assess the frequency, severity level and risk factors associated with pDDIs among medications used to treat hypertensive ambulatory patients in Universitas Airlangga hospital. Methods: A retrospective observational study was carried out from electronic prescriptions received by hypertensive patients in March 2021. Data collection includes demographic data, the profile of antihypertensive drug use, and pDDIs. pDDIs were identified by severity using Lexicomp Drug Interaction Checker (Application). Univariate logistic regression analysis was used to find associated factors of major pDDIs. A p-value less than 0.05 (â‰¤ 0.05) was considered statistically significant. Results: From 704 patients, 53.98% women and 46.02% men, 89.06% (n = 627) patients had minor to major pDDIs; 1354 pDDIs were identified, 89.4% (n = 1,210) were moderate and 9.8% (n = 133) were major class. Multiple antihypertensive drug regimens had significance associated with the major pDDIs occurrence. Conclusion: We found a high prevalence of pDDIs among hypertensive patients. The majority of pDDIs were of moderate severity. Multiple antihypertensive drug regimens were associated factors in the presence of major pDDIs.

Prevalensi dan Identifikasi Berdasarkan Sekuen ITS Kapang Patogen Batang Tanaman Apel Var. Anna (Malus sylvestris (L.) Mill.) di Kota Batu Ilham Rizqy Isnain; Suharjono Suharjono
Biotropika: Journal of Tropical Biology Vol 2, No 5 (2014)
Publisher : University of Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar

ABSTRAK Penurunan jumlah pohon apel produktif mengakibatkan rendahnya daya saing apel di dalam negeri. Berkurangnya jumlah tanaman apel produktif salah satunya disebabkan oleh kapang patogen. Penelitian ini bertujuan untuk mengidentifikasi spesies kapang patogen yang menyerang batang tanaman apel berdasarkan sekuen ITS. Sampel diambil dari perkebunan Gabes, Dusun Junggo, Desa Tulungrejo Kecamatan Bumiaji, Kota Batu. Kapang diisolasi dari lima batang bergejala penyakit dan dimurnikan, diuji patogenisitas terhadap bibit tanaman apel, isolasi DNA, dan identifikasi molekular. Berdasarkan hasil penelitian gejala AN3 banyak ditemui pada perkebunan organik dengan prevalensi 59,6 , sedangkan gejala AN5 merupakan gejala penyakit yang paling sedikit dengan prevalensi 1,69. Isolat AN5.2 teridentifikasi sebagai Neofusicoccum parvum yang menyebabkan penyakit busuk kering dan berakibat kematian pada batang, sedangkan isolat AN3.2 teridentifikasi sebagai Aureobasidium pullulans. Kata kunci: Aureobasidium pullulans, identifikasi molekular, kapang patogen, Malus sylvestris Mill., Neofusicoccum parvum

Effect of Atorvastatin in Lipid Profile Changes and Inflammation Marker TNF-alpha on Diabetes Patient with Dyslipidemia Wulan Panduwi Melasari; Suharjono Suharjono; Wiwid Samsulhadi
Folia Medica Indonesiana Vol. 57 No. 1 (2021): March
Publisher : Universitas Airlangga

Diabetes is one of the risk factors for cardiovascular disease (CVD). Diabetics patients have 2 to 4 times increased risk of cardiovascular disease compared with non-diabetics. TNF-alpha is a proinflammatory cytokine that can be used to determine the risk of atherosclerosis complications triggered by inflammation in diabetes. Statins are a class of HMG CoA reductase inhibitors that inhibit cholesterol biosynthesis and have pleioropic effects that inhibit the release of inflammatory cytokines likeTNF-alpha and stabilize atherosclerotic plaques. This study aims to determine the effect of atorvastatin 20 mg/day for 30 days in reducing the lipid profile and TNF-alpha inflammatory markers in patients with diabetes dyslipidemia. Diabetes patient with dyslipidemia who included the inclusion criteria in this observational prospective cohorts studies treated with atorvastatin for 30 days (n = 19). The efficacy of statin therapy was measured by lipid profiles (LDL, TG, HDL, and total cholesterol) and TNF-alpha. The results of the study showed that atorvastatin decreased 40.55% of LDL levels, 15.34% of TG levels, and 30.70% oftotal cholesterol levels which statistically significant (P <0.05). As for HDL, there is an increase of 6.06% but statistically non-significant (P >0.05). TNF-alpha levels increased by 11.30% which statistically non-significant (P >0.05). The use of atorvastatin 20 mg for 30 days gave reduction in LDL, TG, and total cholesterol and increased in HDL. Atorvastatin does not have a reducing effect on TNF-alpha. There was no correlation between lipid profile changes with TNF-alpha changes.

Penelitian pembuatan kulit nappa dari kulit domba untuk garmen Emiliana Kasmudjiastuti; Emy Sulistyo Astuti; Widhiati Widhiati; Suharjono Suharjono; Jaka Susila; Kuwatno Kuwatno; Suryadi Suryadi
Majalah Kulit, Karet, dan Plastik Vol 12, No 22 (1996): Majalah Barang Kulit, Karet, dan Plastik
Publisher : Center for Leather, Rubber, and Plastic Ministry of Industry, Indonesia

The purpose of this study is to know the best of variation of retaninagent. Material used in this study are 30 pieces sheep skin wet blue leather while retanning agent added in three variables are Chrome-Blancorol, Chrome Lutan, Chrome-Tanesco. The results of the study were tested on their chemical, physical and visual properties. The data which are statistically analyzed using Completely Randomized Design (CRD) and Least Significant Difference (LSD) show that the best result is obtained by the sheep skins which are retannned using combination of chrome-Tanesco with stitch tear strength = 722.09 N/ cm, tear strength = 140.45 N/ cm, chrome content = 4.4 %, dry rub fastness test show no discolourisation, while wet rub fastness test show a little discolourisation and resistance of dry cleaning to perchloroetylene. INTISARI Penelitian ini bertujuan untuk mengetahui kombinasi bahan penyamakan ulang terbaik pada pembuatan kulit nappa dari kulit domba untuk garmen. Bahan yang digunakan dalam penelitian ini sebanyak 30 lembar kulit domba belahan krom basah (wet blue). Bahan penyamak ulang yang digunakan adalah dengan 3 (tiga) macam variasi : Krom – Blancorol, Krom – Lutan dan Krom Tanesco. Kulit nappa hasil penelitian diuji secara kimiawi, fisis dan organleptis. Hasil analisa statistic dengan CRD dan LSD menunjukkan bahwa hasil terbaik dicapai oleh kulit nappa yang disamak ulang dengan kombinasi Krom Tanesco dengan nilai kekuatan jahit = 722,09 N /cm, Kekuatan sobek = 140, 45 N/cm, kadar krom = 4,40 %, ketahanan gosok cat tutup tidak luntur (secara kering) dan sedikit luntur (secara basah), serta tahan terhadap pencucian kering dengan perchloro ethylene.

PENINGKATAN KOMPETENSI DAN PENGETAHUAN APOTEKER TERHADAP OBAT OFF LABEL MELALUI WORKSHOP AND TRAINING Suharjono Suharjono; Mahardian Rahmadi; Chrismawan Ardianto; Arina Dery Puspitasari; Dewi Wara Shinta
Jurnal Layanan Masyarakat (Journal of Public Services) Vol. 2 No. 2 (2018): Jurnal Layanan Masyarakat
Publisher : Universitas Airlangga

Drug information off label is not widely known and understood by health workers, both doctors and pharmacists. Prescribing drugs off label will also have an impact on ethical rules and drug costs, whether legal and can be covered by insurance. Therefore, there needs to be a continuing education activity for Pharmacists and health professionals to provide information and understanding of participants with the development of drugs off the label. This activity aims to improve the competencies of the participants, as well as understand the legal prescribing rules and as input for insurance and pharmaceutical regulations. The form of activities that will be carried out are workshops and training. The event was held for 2 days, 14-15 October 2018 at Graha Iptekdok, FKUA. There are 10 resource persons with 11 materials divided into 6 workshops, and 1 Micromedex training activity. This activity was attended by 383 participants and 5 invitations. Among the 383 participants, 55% were pharmacists working in hospitals, 30% were pharmacists working in pharmacies, and the rest were pharmacists working in industries, health centers, health services, and pharmacy students. Domicile participants come from various regions, with the largest percentage from Java. Based on the results of the questionnaire evaluation, the average material suitability assessment with participants’ needs was 8 out of 10. On the other hand, the material mastery by the speakers was also very good (8 out of 10). While in terms of the event, the average participant rated very well (7-9 of a scale of 10). A value of 7 is given to the parameters of room facilities. Seeing the enthusiasm of the participants of the Off Label Workshop andTraining in Community and Clinical Settings, the committee plans to follow up by holding a similar event to accommodate potential participants who cannot be accommodated in this event.AbstrakInformasi obat off label belum banyak diketahui dan dipahami oleh para tenaga kesehatan, baik dokter maupun apoteker. Peresepan obat off label juga akan berdampak pada aturan etik dan biaya obat, apakah legal dan bisakah ditanggung oleh asuransi. Oleh sebab itu, perlu adanya suatu kegiatan pendidikan berkelanjutan kepada para Apoteker dan profesi kesehatan untuk memberikan informasi dan pemahaman peserta dengan perkembangan obat off label. Kegiatan ini bertujuan untuk meningkatkan kompetensi para peserta, juga memahami aturan peresepan yang legal dan sebagai masukan untuk asuransi serta peraturan farmasi. Bentuk kegiatan yang akan dilakukan adalah workshop dan training. Acara dilakukan selama 2 hari, 14–15 Oktober 2018 di Graha Iptekdok, FKUA. Terdapat 10 narasumber dengan 11 materi yang dibagi dalam 6 workshop, dan 1 kegiatan pelatihan Micromedex. Kegiatan ini dihadiri oleh 383 peserta dan 5 undangan. Diantara 383 peserta, 55% merupakan apoteker yang bekerja di rumah sakit, 30% adalah apoteker yang bekerja di apotek, dan sisanya adalah apoteker yang bekerja di industri, puskesmas, dinas kesehatan, dan mahasiswa farmasi. Domisili peserta berasal dari berbagai daerah, dengan prosentase terbesar dari Jawa. Berdasarkan hasil evaluasi kuesioner, rata-rata penilaian kesesuaian materi dengan kebutuhan peserta adalah 8 dari skala 10. Selain itu, penguasaan materi oleh narasumber juga sangat baik (8 dari skala 10). Sedangkan dari segi acara, rata-rata peserta menilai sangat baik (7–9 dari skala 10). Nilai 7 diberikan pada parameter fasilitas ruangan. Melihat antusiasme dari peserta off Label Drugs Workshop and Training in Community and Clinical Settings, maka panitia berencana akan melakukan tindak lanjut dengan mengadakan acara yang serupa untuk mengakomodir calon peserta yang tidak dapat tertampung pada acara ini.

INFLUENCE OF ISONIAZID ON THE METABOLISM OF RIFAMPICIN ON MT HEPATOCYTES Fasich Fasich; Suharjono Suharjono; I Ketut Mandikin; Mulja Hadi Santosa
JURNAL PENELITIAN BIOLOGI BERKALA PENELITIAN HAYATI Vol 5 No 2 (2000): June 2000
Publisher : The East Java Biological Society

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.23869/474

Research on the influence of isoniazid on rifampicin metabolism using rat hepatocytes has been done. As the system metabolism, hepatocytes suspension was prepared by perfusion in the calcium binding media containing EDTA, citrate and glycine was used. In the experiment, combination of rifampicin and INH on various doses was incubated in those metabolism system at 30oC from 0 and up to 180 minutes duration. Then, analysis was done by thin layer chromathography and densitomeric method for each incubation intervals. Result calculated on the base of variation of rifampicin AUC-value beginning from 0 up to 180 minutes showed that isoniazid with concentration 5 µl, 10 µl, 15 µl, and 20 µl did not influence the metabolism of rifampicin (10 µl/ml) as showed by no significance changes of AUC value of rifampicin for Î± = 0.05.

Analisis Penggunaan Antibiotika pada Pasien Penyakit Dalam di RSUD Dr. H. Slamet Martodirdjo Pamekasan dengan Metode ATC/DDD Achmad Ridwan; Lisa Narulita; Elvan Dwi Widyadi; Suharjono Suharjono
Jurnal Sains Farmasi & Klinis Vol 6, No 3 (2019): J Sains Farm Klin 6(3), Desember 2019
Publisher : Fakultas Farmasi Universitas Andalas

Resistensi antimikroba (AMR) merupakan masalah kesehatan yang mendunia. Resistensi tidak dapat dihilangkan namun dapat diperlambat dengan cara menggunakan antibiotika secara bijak. Salah satu cara yang dapat dilakukan untuk menanggulangi resistensi antimikroba dengan melakukan evaluasi penggunaan antibiotika baik secara kuantitatif maupun kualitatif. Tujuan penelitian ini adalah untuk mengetahui pola penggunaan antibiotika pada pasien ilmu penyakit dalam RSUD Dr. H. Slamet Martodirdjo Pamekasan selama periode Januari-Maret 2019. Penelitian ini merupakan penelitian deskriptif-analitik (cross-sectional) dengan pengambilan data secara retrospektif serta jumlah sampel 482 pasien yang selanjutnya dianalisis menggunakan metode ATC dan DDD. Hasil penelitian menunjukkan nilai total DDD pemakaian antibiotika adalah 76,03/100 patient-days dengan total LOS pasien adalah 2270 hari. Penggunaan antibiotika tertinggi adalah ceftriaxone 37,56/100 patient-days, ciprofloxacin 25,78/100 patient-days, dan levofloxacin 6,05/100 patient-days. Golongan antibiotika yang masuk ke dalam segmen DU 90% yaitu ceftriaxone, ciprofloxacin, dan levofloxacin, sehingga harus dipantau penggunaannya karena berpotensi pada risiko resistensi. Kedepan perlu dilakukan penelitian lanjutan terkait evaluasi kualitas penggunaan antibiotika, serta dilakukan intervensi yang tepat untuk meningkatkan penggunaan antibiotika secara bijak dengan harapan dapat menekan angka resistensi antibiotika.

Pengaruh Penambahan Fucoidan Pada Omeprazol Terhadap Perbaikan Gejala Dispepsia dan Kualitas Hidup Pada Pasien Dispepsia Fungsional Khaerani Khaerani; Suharjono Suharjono; Bambang Eko Wahyono
PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Jurnal Pharmacy, Vol. 18 No. 01 Juli 2021
Publisher : Pharmacy Faculty, Universitas Muhammadiyah Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30595/pharmacy.v18i1.7568

Dispepsia Fungsional merupakan salah satu gangguan fungsi pada gastrointestinal dan dapat berpengaruh terhadap kualitas hidup pasien. Fucoidan memiliki banyak efek farmakologi, salah satunya sebagai mukoprotektor dan bersifat sebagai anti ulcer pada gastrointestinal yang diduga dapat memperbaiki gejala dispepsia. Tujuan dari penelitian ini yaitu menganalisis efek penambahan fucoidan pada omeprazol terhadap perbaikan gejala dispepsia dan kualitas hidup pasien pada pasien dispepsia fungsional. Hasil yang diperoleh adanya perbaikan gejala dan kualitas hidup sebelum dan setelah menerima penambahan terapi fucoidan dengan nilai p < 0,05. Pada perbandingan perbaikan yang dilakukan pada kedua kelompok tidak terjadi perbaikan yang signifikan secara statistik dengan nilai p > 0,05 untuk beberapa domain kuesioner. Akan tetapi dalam perbaikan gejala klinik yang diobservasi terdapat perbaikan gejala dispepsia dan kualitas hidup yang lebih baik pada penambahan fucoidan.

Molnupiravir - the First Oral Antiviral for COVID-19: A Literature Review Nur Afni; Suharjono Suharjono
Pharmacon: Jurnal Farmasi Indonesia Vol 19, No 1 (2022)
Publisher : Universitas Muhammadiyah Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.23917/pharmacon.v19i1.17330

The COVID-19 pandemic is still an unresolved global health concern, although half of the world's population has been vaccinated. The pharmaceutical industries are still struggling to develop effective antivirals against SARS-CoV-2. Molnupiravir is a new oral antiviral with antiviral properties by targeting coronavirus RNA. This literature review aims to describe the mechanism of action, efficacy, and safety of molnupiravir based on published preclinical and clinical studies for COVID-19 treatment. Relevant studies were collected by electronic databases, including Google Scholar, PubMed, and Science Direct. The inclusion criteria were preclinical and clinical trials related to molnupiravir as an antiviral for the COVID-19 treatment published in December 2019 to January 2022. Preclinical trials demonstrated therapeutic and prophylactic properties against SARS-CoV-2 in cell culture and animal models. Molnupiravir is currently under the emergency use authorization from the FDA to treat COVID-19. Its potent and broad antiviral activity is demonstrated through a mechanism of error catastrophe that causes coronavirus RNA mutagenesis. The published clinical trials have shown that molnupiravir is well-absorbed, well-tolerated, and has relatively mild side effects such as headache, nausea, and diarrhea with a minimal incidence at a dose of 800 mg twice daily. Time to viral RNA clearance was significantly decreased in patients administered molnupiravir 800 mg compared to those who administered placebo (14 days vs 15 days, P value=0,013). Molnupiravir is a promising oral antiviral that can reduce the incidence of COVID-19 hospitalization or death. Further clinical trials regarding its efficacy for severe symptoms and other clinical aspects such as drug interactions and contraindications are still needed.

Herbs Used as Antidiabetic : A Review Jufri Ubrusun; Suharjono Suharjono; Irma Novrianti
Ad-Dawaa: Journal of Pharmaceutical Sciences Vol 4 No 2 (2021)
Publisher : Universitas Islam Negeri Alauddin Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24252/djps.v4i2.23461

Diabetes mellitus is a syndrome characterized by a condition of hyperglycemia, and changes in the metabolism of lipids, carbohydrates, and proteins. Diabetes mellitus is characterized by an increase in glucose levels caused by insulin deficiency either in absolute or relative terms. Diabetes mellitus therapy is a long-term therapy and is relatively expensive. Therefore, it is necessary to look for effective alternative drugs with low prices such as herbal medicines derived from plants. Indonesia is one of the countries that has a diversity of plants, so many plants that grow in Indonesia can be used as an alternative therapy to overcome diabetes mellitus. This paper aims to provide a relevant review of medicinal plants used for diabetes mellitus that has been carried out in research on tested animals. This research was conducted by searching for national and international articles from the internet, which were searched from 2011 to 2019, including original articles, and experimental articles, about Traditional medicine for diabetics. The following keywords are used : [[ “studi in vivo tumbuhan obat untuk diabetes” OR “Uji efektifitas ekstrak tumbuhan sebagai antidiabetik” OR “tumbuhan sebagai antidiabetik” ]] OR [["Test extract activity against diabetic mice" OR "antidiabetic plant" OR "antidiabetic herbal medicine" OR "antidiabetic in rat”, “Traditional medicine of diabetisin Indonesia” ]]. From the results of the literature study, it was found that 21 articles with 24 medicinal plants were tested in vivo on test animals to reduce blood sugar in diabetes mellitus. These medicinal plants contain compounds of the type of flavonoids, alkaloids, tannins, saponins, polyphenols, terpenoids, and phenolics that can have a therapeutic effect on decreasing blood sugar levels in test animals.

Co-Authors A.A. Ketut Agung Cahyawan W Achmad Ridwan Achmad Ridwan, Achmad Agriawan Sudirman Ahmad Nasir ahmad, abraham Andri Geger Noviantoro Aprillia Wijaya, Stefani Ari Wibowo Arief Bachtiar Arina Dery Puspitasari Assiddiqy, Miftah Farid Atmajani, Wanudya Bagiyo, Harry Bagiyo, Harry Bagyo Yanuwiadi Bambang Eko Wahyono Bambang Sidharta Bambang Sudarmanto Budi Suprapti Budiatin, Aniek Setya Budiatin, Aniek Setya Chairunnisa Chairunnisa Chris Alderman Chrismawan A, Chrismawan A Chrismawan Ardianto Dea Ayu Nabilah Debora Shinta Liana Desiani, Ekanita Dewi Wara Shinta Didik Hasmono Dinda Monika Nusantara Ratri Diniah, Melisa Nur Djafar, Zaenab Dwiyatna, Surya Elvan Dwi Widyadi Emiliana Kasmudjiastuti Emy Sulistyo Astuti Endang Retnowati Eni Susanti Faizal Mustamin Fandyka Yufriza Ali Fasich Fasich Fransiska Maria Christianty Gratia, Veronica Hari Prasetyo Hasria Alang Heru Purwanto Hubby, Hubby I Gede Edy Sagitha I Ketut Mandikin Ilham Rizqy Isnain Imam Faozi Imam Susilo Indira D. Kharismawati Irfan Mustafa Irma Novrianti Irma Novrianti Irvina Harini Isnaeni Jaka Susila Jikrona, Rafi Joni Kusnadi Joni Wahyuhadi, Joni Jufri Ubrusun Junaidi Khotib Kenyo Alexandra Oktaviani Khaerani Khaerani Khusnul Fitri Hamidah Kusuma Arum Ningsih Kuwatno Kuwatno Lestiono, . Lestiono, . Lewi Tigor Simorangkir Lisa Narulita Lisa Narulita Liziyyannida Liziyyannida M. Yusuf Assegaf Mahardian R, Mahardian R Mahardian Rahmadi Mahfudz Mahfudz Makitalentu, Feybe Marcha Debby Saraswati Mareta Rindang Andarsari Medina, Farah Meita Rafika Fitriani Mohammad Akram Muhammad Aminuddin, Muhammad Muhammad Fathoni, Muhammad Mulja Hadi Santosa Narulita, Lisa Nasir, Ahmad Neldi, Vina Nia Kurniawan Nur Afni NUR CHAKIM Nurmainah Nurmainah Nurrofik, Agus Paulus Sugianto Prasetyanti, Intan Kris Prastuti Asta Wulaningrum Pratita, Dian Galuh Primadi Avianto Purwanto, Diyna Rusayliya Rahman, Gilang Mauladi Rahmawati Raising Ria Rositasati Riefkah Bilal risha fillah fithria Risthanti, Reine Risa Rosdiana, Eva Rudi Safarudin Rudi Wardana Rusdiana, Silvia Rusdiana, Silvia Safarudin, Rudi Sahayuna, Dara Demi Samirah Samirah Samirah Samirah, Samirah Sari, Erni A Semedi S J Shafira Muti Ardiana Shahroni, Abdul Mutholib Shofia Ummu, Lathifa Simorangkir, Lewi Tigor Sindy, Sulih Probo SJ, Semedi Solihin, Imron Sudirman, Agriawan Sukardiman Sumarno . Sumarno Sumarno Suryadi Suryadi Susilo, Dwi Hari Sutrisnaningsih, Evy Sari Suwardi Suwardi Toetik Aryani Tri Ardyati Umami, Zahra Veronica Gratia WENNY PUTRI NILAMSARI Widhiati Widhiati Widyadi, Elvan Dwi Wiwid Samsulhadi Wulan Panduwi Melasari Yance Anas yance yance Yen Yen Ari Indrawijaya YOGA DWI JATMIKO Yogiarto Yogiarto Yulia Ayu Purnamasari Yulistiani Yulistiani Yulistiani Yulistiani, Yulistiani Yulistiani, . Yuniati T Yuniati T Yuniati T, Yuniati Yusfar, Yunarti Yustiana Yustiana, Yustiana Zamrotul Izzah Zulfiana, Risa

Title

Found 66 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 66 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 66 Documents
Search